Ratings for Ulta Beauty ULTA were provided by 37 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 6 | 10 | 18 | 2 | 1 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 1 | 2 | 7 | 1 | 0 |
| 2M Ago | 5 | 4 | 7 | 1 | 1 |
| 3M Ago | 0 | 4 | 3 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $442.68, a high estimate of $538.00, and a low estimate of $330.00. Surpassing the previous average price target of $415.05, the current average has increased by 6.66%.
Deciphering Analyst Ratings: An In-Depth Analysis
The standing of Ulta Beauty among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Adrienne Yih | Barclays | Raises | Equal-Weight | $445.00 | $410.00 |
| Oliver Chen | TD Cowen | Raises | Hold | $480.00 | $450.00 |
| Susan Anderson | Canaccord Genuity | Raises | Buy | $538.00 | $500.00 |
| Kelly Crago | Citigroup | Raises | Neutral | $457.00 | $450.00 |
| Lorraine Hutchinson | B of A Securities | Raises | Neutral | $475.00 | $460.00 |
| Anna Glaessgen | B. Riley Securities | Raises | Neutral | $430.00 | $330.00 |
| Mark Astrachan | Stifel | Raises | Hold | $475.00 | $455.00 |
| Ike Boruchow | Wells Fargo | Raises | Underweight | $370.00 | $350.00 |
| Korinne Wolfmeyer | Piper Sandler | Raises | Neutral | $425.00 | $394.00 |
| Rupesh Parikh | Oppenheimer | Raises | Outperform | $515.00 | $505.00 |
| Dana Telsey | Telsey Advisory Group | Maintains | Outperform | $500.00 | $500.00 |
| Korinne Wolfmeyer | Piper Sandler | Raises | Neutral | $394.00 | $390.00 |
| Anthony Chukumba | Loop Capital | Raises | Buy | $480.00 | $450.00 |
| Michael Lasser | UBS | Raises | Buy | $490.00 | $470.00 |
| Kelly Crago | Citigroup | Raises | Neutral | $450.00 | $390.00 |
| Adrienne Yih | Barclays | Raises | Equal-Weight | $410.00 | $335.00 |
| Michael Baker | DA Davidson | Raises | Buy | $510.00 | $435.00 |
| Anna Glaessgen | B. Riley Securities | Raises | Sell | $330.00 | $300.00 |
| Simeon Siegel | BMO Capital | Raises | Market Perform | $420.00 | $385.00 |
| Rupesh Parikh | Oppenheimer | Raises | Outperform | $505.00 | $435.00 |
| Christopher Horvers | JP Morgan | Raises | Overweight | $480.00 | $472.00 |
| Mark Astrachan | Stifel | Raises | Hold | $455.00 | $395.00 |
| Ike Boruchow | Wells Fargo | Raises | Underweight | $350.00 | $300.00 |
| Korinne Wolfmeyer | Piper Sandler | Raises | Neutral | $390.00 | $360.00 |
| Susan Anderson | Canaccord Genuity | Raises | Buy | $500.00 | $476.00 |
| Dana Telsey | Telsey Advisory Group | Raises | Outperform | $500.00 | $450.00 |
| Korinne Wolfmeyer | Piper Sandler | Raises | Neutral | $360.00 | $357.00 |
| Susan Anderson | Canaccord Genuity | Raises | Buy | $476.00 | $442.00 |
| Kelly Crago | Citigroup | Raises | Neutral | $390.00 | $345.00 |
| Dana Telsey | Telsey Advisory Group | Maintains | Outperform | $450.00 | $450.00 |
| Christopher Horvers | JP Morgan | Raises | Overweight | $472.00 | $450.00 |
| Oliver Chen | TD Cowen | Lowers | Hold | $380.00 | $390.00 |
| Mark Astrachan | Stifel | Raises | Hold | $395.00 | $385.00 |
| Dana Telsey | Telsey Advisory Group | Maintains | Outperform | $450.00 | $450.00 |
| Korinne Wolfmeyer | Piper Sandler | Raises | Neutral | $357.00 | $356.00 |
| Rupesh Parikh | Oppenheimer | Maintains | Outperform | $435.00 | $435.00 |
| Olivia Tong | Raymond James | Lowers | Outperform | $440.00 | $450.00 |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Ulta Beauty. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Ulta Beauty compared to the broader market.
- Price Targets: Analysts predict movements in price targets, offering estimates for Ulta Beauty's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.
To gain a panoramic view of Ulta Beauty's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on Ulta Beauty analyst ratings.
All You Need to Know About Ulta Beauty
With more than 1,400 freestanding stores and a partnership with Target, Ulta Beauty is the largest specialized beauty retailer in the US. The firm offers makeup (41% of 2023 sales), fragrances, skin care (19% of sales), and hair care products (19% of sales), and bath and body items. Ulta offers private-label products and more than 600 individual brands. It also offers salon services, including hair, makeup, skin, and brow services, in all stores. Most Ulta stores are approximately 10,000 square feet and are in suburban strip centers. The firm intends to open franchises in Mexico in 2025. Ulta was founded in 1990 and is based in Bolingbrook, Illinois.
Unraveling the Financial Story of Ulta Beauty
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: Ulta Beauty's revenue growth over a period of 3 months has been noteworthy. As of 31 October, 2024, the company achieved a revenue growth rate of approximately 1.65%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Discretionary sector.
Net Margin: Ulta Beauty's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 9.57%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Ulta Beauty's ROE stands out, surpassing industry averages. With an impressive ROE of 10.36%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Ulta Beauty's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 4.14% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a below-average debt-to-equity ratio of 0.92, Ulta Beauty adopts a prudent financial strategy, indicating a balanced approach to debt management.
How Are Analyst Ratings Determined?
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
